Package Leaflet: Information for the User
Rixacam 15 mg Hard Capsules EFG
rivaroxaban
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Rixacam contains the active substance rivaroxaban.
Rivaroxaban is used in adults to:
Rixacam is used in children and adolescents under 18 years of age and with a body weight of 30 kg or more to:
Rivaroxaban belongs to a group of medicines called antithrombotic agents. It works by blocking a factor in the blood clotting process (factor Xa) and thus reduces the tendency of the blood to form clots.
Do not take Rixacam
Do not take Rixacam and inform your doctorif any of these circumstances apply to you.
Warnings and precautions
Consult your doctor or pharmacist before starting this medicine.
Be particularly careful with this medicine
Inform your doctor if you have any of these conditionsbefore taking this medicine. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If you need to have surgery
Children and adolescents
Rixacam 15 mg is not recommended in children with a body weight below 30 kg.
There is not enough information about the use of this medicine in children and adolescents for the indications in adults.
Other medicines and Rixacam
Inform your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including those obtained without a prescription.
If any of the above circumstances apply to you, inform your doctorbefore taking this medicine, as the effect of this medicine may be increased. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing a stomach or intestinal ulcer, they may recommend using a preventive treatment for ulcers in addition.
If any of the above circumstances apply to you, inform your doctorbefore taking this medicine, as the effect of this medicine may be reduced. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
Pregnancy and breastfeeding
Do not take this medicine if you are pregnant or breastfeeding. If there is a possibility that you may become pregnant, use a reliable contraceptive while taking this medicine. If you become pregnant while taking this medicine, inform your doctor immediately, who will decide how you should be treated.
Driving and using machines
This medicine may cause dizziness (a common side effect) or fainting (an uncommon side effect) (see section 4, "Possible side effects"). Do not drive, ride a bicycle or use tools or machines if you are affected by these symptoms.
Rixacam contains lactose monohydrate (a type of sugar) and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per capsule; this is, essentially "sodium-free".
Follow exactly the administration instructions of this medicine indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
You must take this medicine with food.
Swallow the capsule preferably with water.
If you have difficulty swallowing the capsule whole, consult your doctor about other ways to take Rixacam. The contents of the capsule can be mixed with water or apple puree immediately before taking it.
This mixture should be followed immediately by food.
If necessary, your doctor may also administer the contents of the Rixacam capsule sprinkled through a gastric tube.
What dose to take
The recommended dose is one rivaroxaban 20 mg capsule once a day.
If you have kidney problems, the dose may be reduced to one rivaroxaban 15 mg capsule once a day.
If you need to undergo a procedure to treat blocked blood vessels in your heart (called percutaneous coronary intervention - PCI with stent insertion), there is limited evidence to reduce the dose to one rivaroxaban 15 mg capsule once a day (or to one rivaroxaban 10 mg capsule once a day in case your kidneys do not function properly) in addition to an antiplatelet medicine such as clopidogrel.
The recommended dose is one rivaroxaban 15 mg capsule twice a day for the first 3 weeks. For treatment after 3 weeks, the recommended dose is one rivaroxaban 20 mg capsule once a day.
After at least 6 months of treatment for blood clots, your doctor may decide to continue treatment with one 10 mg capsule once a day or one 20 mg capsule once a day.
If you have kidney problems and are taking one rivaroxaban 20 mg capsule once a day, your doctor may decide to reduce the treatment dose to one rivaroxaban 15 mg capsule once a day after 3 weeks if the risk of bleeding is higher than the risk of having another blood clot.
The dose of Rixacam depends on body weight and will be calculated by the doctor.
Take each dose of rivaroxaban with a drink (e.g. water or juice) during a meal. Take the capsules every day at approximately the same time. Consider setting an alarm to remind you. For parents or caregivers: observe the child to ensure they take the entire dose.
Since the dose of Rixacam is based on body weight, it is important to attend scheduled visits with the doctor, as it may be necessary to adjust the dose as weight changes.
Never adjust the dose of Rixacam on your own. Your doctor will adjust the dose if necessary.
Do not pour the contents of the capsule in an attempt to provide a fraction of the capsule dose. If you need a smaller dose, use the alternative product that contains rivaroxaban in the form of oral suspension granules.
For children and adolescents who cannot swallow the capsules whole, use a product that contains rivaroxaban in the form of oral suspension granules.
If you do not have the oral suspension, you can pour the contents of the Rixacam capsule and mix it with water or apple puree immediately before taking it. Take some food after taking this mixture. If necessary, your doctor may also administer the contents of the Rixacam capsule sprinkled through a gastric tube.
If you spit out the dose or vomit
Call your doctor if you spit out the dose or vomit repeatedly after taking this medicine.
When to take Rixacam
Take the capsule(s) every day, until your doctor tells you to stop.
Try to take the capsules at the same time every day to remember when to take them.
Your doctor will decide how long you should continue taking the treatment.
To prevent the formation of blood clots in the brain (stroke) or in other blood vessels:
If it is necessary to normalize your heartbeat through a procedure called cardioversion, take this medicine at the times indicated by your doctor.
If you take more Rixacam than you should
Call your doctor immediately if you have taken too many capsules of this medicine. Taking too much rivaroxaban increases the risk of bleeding.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Rixacam
If you are taking one 15 mg capsule oncea day, and you forget to take a dose, take it as soon as you remember. Do not take more than one capsule in one day to make up for a forgotten dose. Take the next capsule the next day and, after that, continue taking one capsule every day.
If you are taking one 15 mg capsule twicea day, and you forget to take a dose, take it as soon as you remember. Do not take more than two 15 mg capsules in one day. If you forget to take a dose, you can take two 15 mg capsules at the same time, for a total of two capsules (30 mg) in one day. The next day, you should continue taking one 15 mg capsule twice a day.
If you stop taking Rixacam
Do not stop taking this medicine without talking to your doctor first, as this medicine treats and prevents serious conditions.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Like other similar medicines to reduce blood clot formation, this medicine can cause bleeding that can put the patient's life at risk. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be evident.
Tellyour doctor immediately if you or your child experience any of the following adverse effects:
Your doctor may decide to keep you under closer observation or change your treatment.
The frequency of these adverse effects is very rare (up to 1 in 10,000 people).
The frequencies of severe allergic reactions are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people)
General list of possible adverse effectsfound in adults, children, and adolescents
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(frequency cannot be estimated from available data)
Adverse effects in children and adolescents
In general, the adverse effects observed in children and adolescents treated with this medicine were similar to those observed in adults and their severity was mainly mild to moderate
Adverse effects that were more frequently observed in children and adolescents:
Very frequent(may affect more than 1 in 10 people)
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine
Keep this medicine out of the sight and reach of children
Do not use this medicine after the expiration date that appears on the blister pack and on the packaging after CAD. The expiration date is the last day of the month indicated
PVC/PVdC/Al blisters: Do not store above 30 °C. Store in the original packaging to protect from moisture
Al/Al blisters: No special storage conditions are required
Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines you no longer need at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment
Rixacam composition
Appearance of the product and package contents
Rixacam 15 mg hard capsules are a white to off-white powder presented in size "1" (approximately 19 mm long) capsules with opaque light brown cap and body
The hard capsules are packaged in PVC/PVdC/Al or Al/Al blisters
Rixacam 15 mg is available in packs of 14, 28, 42, or 98 hard capsules
Only some pack sizes may be marketed
Marketing authorization holder
Adamed Laboratorios, S.L.U
c/ de las Rosas de Aravaca, 31 - 2ª planta
28023 Madrid
Spain
Manufacturer
Adamed Pharma S.A
ul. marsz J. Pilsudskiego 5, Pabianice, 95-200
Poland
or
Zentiva S.A
B-dul Theodor Pallady nr. 50, sector 3, Bucharest, 032266 Romania
or
Pharmadox Healthcare Ltd
KW20A Kordin Industrial Park, Paola, PLA3000, Malta
This medicine is authorizedin the Member States of the European Economic Area under the following names:
Member State | Medicine name |
Poland | RIXACAM |
Czech Republic | RIXACAM |
Spain | Rixacam 15 mg hard capsules EFG |
Date of last revision of this leaflet: February 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es